Actively Recruiting
Color Vision Loss Progression in Inherited Retinal Dystrophy Patients: Correlations with Retinal Structure and Assessment Using a Novel Color Discrimination Test for Low Vision
Led by Zhongmou Therapeutics · Updated on 2025-12-10
200
Participants Needed
1
Research Sites
16 weeks
Total Duration
On this page
Sponsors
Z
Zhongmou Therapeutics
Lead Sponsor
W
Wuhan University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are studying inherited retinal dystrophies (IRDs), a group of genetic disorders that cause progressive damage to the retina's photoreceptors, leading to vision loss and color vision problems. This observational study aims to understand how color vision deficits relate to changes in retinal structure and genetics in affected individuals, as well as to evaluate a new color vision test designed for people with very poor central vision. The investigation includes a diverse group of IRD patients with various genetic types and disease severities, along with control participants without retinal disease. Participants will undergo a series of assessments including standardized color vision testing, best-corrected visual acuity (BCVA) measurement, and advanced retinal imaging using spectral-domain optical coherence tomography (SD-OCT) to examine the ellipsoid zone and other retinal layers. The new Moji Low-Vision Color Discrimination Test (Moji LVCDT), designed for individuals with severe vision loss, will be compared against established color vision tests to validate its accuracy and usefulness. Both IRD patients and control subjects will complete these evaluations during a single study visit. During the study visit, participants will complete color vision assessments including the Moji LVCDT, Ishihara plates, and the low-vision-adapted Cambridge Color Test to measure chromatic discrimination. Retinal imaging and visual acuity tests will be performed to correlate color vision results with retinal structure. Researchers will analyze the relationship between color vision loss, retinal biomarkers, genetic mutations, and age. The main outcomes include comparing the Moji test’s performance to other tests and assessing its ability to detect color vision in people with extreme low vision. The study aims to improve understanding of color vision loss in IRD and to establish a new tool for evaluating color discrimination in low-vision patients.
CONDITIONS
Brief Title
Natural History Study of Inherited Retinal Diseases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants must be able to verbally identify or describe colors and test stimuli
- IRD group participants must have a confirmed clinical diagnosis of inherited retinal dystrophy
- Control group participants must have no history or clinical evidence of inherited retinal degeneration
- Control group participants must have normal retinal health or only non-retinal eye conditions not affecting retinal function
- Control group participants must have normal or expected-normal color vision
You will not qualify if you...
- Color vision loss caused by non-retinal conditions such as optic neuropathies or cortical vision impairments
- Neurological or optic nerve diseases causing color vision deficiency
- Severe developmental delays or cognitive impairments affecting ability to complete color vision tests
- Psychiatric conditions impairing reliable visual testing
- Recent retinal surgery or drug therapy affecting retinal structure or function
- Any acute intervention that could interfere with stable baseline measurements
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit (in-person)
Duration - Single visit
Participants undergo detailed assessments to evaluate color vision performance and retinal structure using multiple imaging and color vision tests, including the novel Moji Low-Vision Color Discrimination Test.
1 visit (in-person)
Duration - Up to 5 years
Participants are observed over time to understand the progression of color vision loss and retinal structure changes in inherited retinal diseases.
Visits as scheduled during the study period for follow-up assessments
Trial Site Locations
Total: 1 location
1
Renmin Hospital of Wuhan University
Wuhan, China
Actively Recruiting
Research Team
W
Wenhui Zhou
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here